Turmeric May Fight Melanoma - the Most Dangerous Skin Cancer

September 07, 2004

In mice with melanoma, the most dangerous skin cancer, giving Turmeric along with immune stimulating therapy substantially slowed the growth of the melanoma. Both the immune stimulating therapy and the Turmeric had little effect when given separately. The mice treated with both immune stimulating therapy and Turmeric survived substantially longer, 82.8% longer, than mice treated with just one of the agents (Turmeric - 45.7% longer than untreated mice, immunotherapy - 48.6% longer than untreated mice). Additionally, melanoma cells are often resistant to chemotherapy, in this case doxorubicin. When the cells were treated with Turmeric, the cancer cells were more likely to die. The study is published in the September 1st issue of the International Journal of Cancer.

Diabetes Increases the Risk of Heart Failure in Women

Postmenopausal women with diabetes had triple the risk of developing heart failure if they have coronary heart disease. According to the new study the following are risk factors for developing congestive heart failure in women; diabetes, obesity, currently smoking, high blood pressure, heart attack, atrial fibrillation, kidney damage, electrical conduction problems, and heart enlargement of the left side. The study is published in the current issue of Circulation, a journal of the American Heart Assoxiation.